(18MF) Amundi Leveraged MSCI USA - Ratings and Ratios
Leveraged, Equity, Inverse, Trading, Index, MSCI, USA
Description: 18MF Amundi Leveraged MSCI USA
The Amundi ETF Leveraged MSCI USA Daily UCITS ETF is an exchange-traded fund listed on XETRA, providing investors with 2x leveraged exposure to the MSCI USA Index. This ETF is designed for traders seeking to capitalize on short-term movements in the US equity market.
From a technical analysis perspective, the ETFs price action indicates a potential bullish trend. The short-term Simple Moving Average (SMA20) is above the medium-term SMA50, suggesting an upward momentum. However, the long-term SMA200 is still above the current price, indicating a potential resistance level. The Average True Range (ATR) is relatively low, indicating a stable volatility environment.
Fundamentally, the ETFs Assets Under Management (AUM) stand at 501.84M EUR, indicating a moderate level of investor interest. As a leveraged ETF, its essential to consider the underlying indexs performance and the overall market conditions. The MSCI USA Index is a widely followed benchmark, and its performance is closely tied to the US economy and market sentiment.
Using a combination of technical and fundamental analysis, a potential forecast for the ETF could be as follows: if the MSCI USA Index continues to trend upwards, the ETFs price is likely to follow, potentially breaking above the SMA200 resistance level. However, if the index experiences a downturn, the ETFs leveraged nature will amplify the losses. Therefore, traders should closely monitor the underlying index and adjust their positions accordingly. A potential trading strategy could involve setting a stop-loss order below the SMA50 and scaling into positions as the price breaks above the SMA200.
Its also worth noting that leveraged ETFs are designed for short-term trading and may not be suitable for long-term investors due to the potential for significant losses if the market moves against the funds position. As such, traders should have a clear understanding of the ETFs mechanics and risks before investing.
Additional Sources for 18MF ETF
18MF ETF Overview
Market Cap in USD | 589m |
Category | Trading - Leveraged/Inverse Equity |
TER | 0.35% |
IPO / Inception | 2009-06-16 |
18MF ETF Ratings
Growth Rating | 67.2 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -22.5 |
Analysts | - |
Fair Price Momentum | 20.16 EUR |
Fair Price DCF | - |
18MF Dividends
Currently no dividends paid18MF Growth Ratios
Growth Correlation 3m | 74.7% |
Growth Correlation 12m | -0.8% |
Growth Correlation 5y | 84.5% |
CAGR 5y | 24.02% |
CAGR/Max DD 5y | 0.56 |
Sharpe Ratio 12m | 0.28 |
Alpha | -16.38 |
Beta | 1.600 |
Volatility | 20.12% |
Current Volume | 66.2k |
Average Volume 20d | 80.9k |
Stop Loss | 20.6 (-3.7%) |
As of July 12, 2025, the stock is trading at EUR 21.39 with a total of 66,247 shares traded.
Over the past week, the price has changed by +1.42%, over one month by +4.29%, over three months by +30.89% and over the past year by +2.42%.
Yes. Based on ValueRay's Analyses, Amundi Leveraged MSCI USA (XETRA:18MF) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 67.16 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of 18MF is around 20.16 EUR . This means that 18MF is currently overvalued and has a potential downside of -5.75%.
Amundi Leveraged MSCI USA has no consensus analysts rating.
According to our own proprietary Forecast Model, 18MF Amundi Leveraged MSCI USA will be worth about 24.2 in July 2026. The stock is currently trading at 21.39. This means that the stock has a potential upside of +13.09%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 24.2 | 13.1% |